Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Crestwood Advisors Group LLC

Crestwood Advisors Group LLC increased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 6.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,184 shares of the pharmacy operator’s stock after purchasing an additional 1,199 shares during the period. Crestwood Advisors Group LLC’s holdings in Walgreens Boots Alliance were worth $188,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of WBA. First Financial Corp IN lifted its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 885 shares during the period. Golden State Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Venturi Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $28,000. TD Private Client Wealth LLC lifted its stake in Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 3,208 shares during the period. Finally, Sentry Investment Management LLC acquired a new stake in Walgreens Boots Alliance during the 3rd quarter valued at approximately $30,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $11.04 on Thursday. The firm has a market cap of $9.54 billion, a PE ratio of -1.08, a PEG ratio of 1.31 and a beta of 0.64. The firm has a fifty day moving average of $10.44 and a 200 day moving average of $9.71. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the company posted $0.66 EPS. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. As a group, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

WBA has been the subject of several recent research reports. Royal Bank of Canada lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday. Evercore ISI lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Finally, Bank of America lifted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $12.63.

View Our Latest Report on Walgreens Boots Alliance

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.